Does Radial Extracorporeal Shockwave Therapy Applied to the Achilles Tendon Influence Ankle Functionality?
Launched by HYUNJOONG KIM · Jan 6, 2024
Trial Information
Current as of August 19, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a treatment called Radial Extracorporeal Shockwave Therapy to see how it affects ankle functionality in healthy individuals. The therapy uses sound waves to help relax muscles and improve tissue health, which may reduce pain and improve movement in the ankle. While there is some research on how this therapy helps with pain in conditions like plantar fasciitis and knee issues, this study specifically aims to see if it can enhance how well the ankle works.
To participate in this trial, you need to have a low level of ankle pain (rated 0 to 2 on a scale where 0 means no pain and 10 means the worst pain possible) and no problems with ankle function. However, you won't be eligible if you've had certain surgeries on your ankle, have higher pain levels, or have recent ankle fractures. If you qualify, you can expect to receive this therapy and help researchers understand its benefits for ankle movement. The trial is not yet recruiting participants, so keep an eye out for updates if you're interested!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Individuals who have ankle-related pain scores of 0 to 2 on the Numeric Pain Rating Scale (NPRS).
- • Individuals with no functional impairment in the ankle.
- Exclusion Criteria:
- • Individuals who have undergone surgical procedures such as ankle joint arthrodesis.
- • Individuals showing signs of functional impairment in ankle functionality.
- • Individuals with ankle-related pain rated above 3 on the NPRS.
- • Individuals with acute ankle fractures.
About Hyunjoong Kim
Hyunjoong Kim is a dedicated clinical trial sponsor focused on advancing medical research and innovative therapies. With a commitment to enhancing patient care through rigorous scientific investigation, Kim oversees the planning, execution, and management of clinical trials across various therapeutic areas. Emphasizing collaboration with healthcare professionals and regulatory bodies, the sponsor ensures adherence to ethical standards and regulatory compliance, while striving to bring new treatments to market that address unmet medical needs. Through a patient-centered approach and a strong emphasis on data integrity, Hyunjoong Kim is dedicated to driving progress in the field of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seoul, , Korea, Republic Of
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported